يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"Raza, Azra"', وقت الاستعلام: 0.91s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial.

    المؤلفون: Verstovsek, Srdan, Mesa, Ruben A., Gotlib, Jason, Gupta, Vikas, DiPersio, John F., Catalano, John V., Deininger, Michael W. N., Miller, Carole B., Silver, Richard T., Talpaz, Moshe, Winton, Elliott F., Harvey Jr., Jimmie H., Arcasoy, Murat O., Hexner, Elizabeth O., Lyons, Roger M., Paquette, Ronald, Raza, Azra, Jones, Mark, Kornacki, Deanna, Kang Sun

    المصدر: Journal of Hematology & Oncology; 2/22/2017, Vol. 10, p1-14, 14p

    مصطلحات موضوعية: LONG-term health care, MYELOFIBROSIS, PLACEBOS, TREATMENT effectiveness, JANUS kinases, DIAGNOSIS, THERAPEUTICS, RUXOLITINIB

    النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosis.

    المؤلفون: Verstovsek, Srdan, Mesa, Ruben A., Gotlib, Jason, Levy, Richard S., Gupta, Vikas, DiPersio, John F., Catalano, John V., Deininger, Michael, Miller, Carole, Silver, Richard T., Talpaz, Moshe, Winton, Elliott F., Harvey, Jimmie H., Arcasoy, Murat O., Hexner, Elizabeth, Lyons, Roger M., Paquette, Ronald, Raza, Azra, Vaddi, Kris, Erickson‐Viitanen, Susan

    المصدر: British Journal of Haematology; May2013, Vol. 161 Issue 4, p508-516, 9p, 1 Chart, 4 Graphs

    مصطلحات موضوعية: MYELOFIBROSIS, ANTI-inflammatory agents, PLACEBOS, PROGNOSTIC tests, SYMPTOMS, DRUG efficacy, THERAPEUTICS


    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Combination of 5-Azacytidine and Thalidomide for the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia.

    المؤلفون: Raza, Azra1 araza@aptiumoncology.com, Mehdi, Murtaza1, Mumtaz, Muhammad1, Ali, Fahad1, Lascher, Steven2, Galili, Naomi1

    المصدر: Cancer (0008543X). Oct2008, Vol. 113 Issue 7, p1596-1604. 9p. 5 Charts, 2 Graphs.

    مصطلحات موضوعية: *ACUTE myeloid leukemia treatment, *MYELODYSPLASTIC syndromes treatment, *THALIDOMIDE, *BLOOD disease treatment, *BONE marrow diseases, *THERAPEUTICS

    النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Phase II study of topotecan and thalidomide in patients with high-risk myelodysplastic syndromes.

    المؤلفون: Raza, Azra1 (AUTHOR) azra.raza@umass.edu, Lisak, Laurie1 (AUTHOR), Billmeier, Jennifer1 (AUTHOR), Pervaiz, Hassan1 (AUTHOR), Mumtaz, Muhammad1 (AUTHOR), Gohar, Samreen1 (AUTHOR), Wahid, Khalid1 (AUTHOR), Galili, Naomi1 (AUTHOR)

    المصدر: Leukemia & Lymphoma. Mar2006, Vol. 47 Issue 3, p433-440. 8p. 4 Charts, 4 Graphs.

    مصطلحات موضوعية: *DRUG therapy, *ANEMIA, *THERAPEUTICS, *THALIDOMIDE, *BLOOD diseases, *MYELODYSPLASTIC syndromes, *APLASTIC anemia, *NEUTROPENIA, *BONE marrow diseases, *CANCER


    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression

    المؤلفون: Raza, Azra1 azra_raza@rush.edu, Buonamici, Silvia2, Lisak, Laurie1, Tahir, Sarah1, Li, Donglan1, Imran, Mehnaz1, Chaudary, Nusrat Ijaz1, Pervaiz, Hassan1, Gallegos, J. Alejandro1, Alvi, M. Imran1, Mumtaz, Muhammad1, Gezer, Sefer1, Venugopal, Parameswaran1, Reddy, Poluru1, Galili, Naomi1, Candoni, Anna1, Singer, Jack3, Nucifora, Giuseppina2

    المصدر: Leukemia Research. Aug2004, Vol. 28 Issue 8, p791-803. 13p.

    مصطلحات موضوعية: *MYELODYSPLASTIC syndromes, *PATIENTS, *THERAPEUTICS, *SYMPTOMS


    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis.

    المؤلفون: Verstovsek, Srdan, Mesa, Ruben A., Gotlib, Jason, Levy, Richard S., Gupta, Vikas, DiPersio, John F., Catalano, John V., Deininger, Michael, Miller, Carole, Silver, Richard T., Talpaz, Moshe, Winton, Elliott F., Harvey, Jimmie H., Arcasoy, Murat O., Hexner, Elizabeth, Lyons, Roger M., Paquette, Ronald, Raza, Azra, Vaddi, Kris, Erickson-Viitanen, Susan

    المصدر: New England Journal of Medicine. 3/1/2012, Vol. 366 Issue 9, p799-807. 9p. 3 Diagrams.

    مصطلحات موضوعية: *PROTEIN kinase inhibitors, *MYELOFIBROSIS, *PLACEBOS, *SPLEEN, *ANEMIA, *THROMBOCYTOPENIA, *THERAPEUTICS


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث